18 FDG-PET at 1-Month Intervals Is a Better Predictive Marker for GISTs That Are Difficult to Be Diagnosed Histopathologically: A Case Report
Case Reports in Oncological Medicine · 2011
DOI: 10.1155/2011/638794 ↗Kurz gefasst
Fallbericht in der Zeitschrift Case Reports in Oncological Medicine, 2011. Verfasst von Kazunori Otsuka und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Oncology, Akita University Graduate School of Medicine, 1-1-1 Hondo, Akita 010-8543, Japan. Die Arbeit nennt 12 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 3.0).
Abstract (Originalsprache)
Imatinib mesylate is a tyrosine kinase inhibitor of c-KIT and PDGFRA. Imatinib mesylate is an effective drug that can be used as a first-choice agent for treatment of GISTs. Prior to treatment, molecular diagnosis of c-KIT or PDGFRA is necessary; however, in some types of GISTs, it is impossible to obtain a sufficient amount of specimen for diagnosis. An inoperable or marginally resectable GIST in a 79-year-old female was difficult to be diagnosed at a molecular pathological level, and hence, exploratory treatment was initiated using imatinib combined with 18 FDG-PET evaluation at 1-month intervals. PET imaging indicated a positive response, and so we continued imatinib treatment in an NAC setting for 4 months. As a result, curative resection of the entire tumor was successfully performed with organ preservation and minimally invasive surgery. 18 FDG-PET evaluation at 1-month intervals is beneficial for GISTs that are difficult to be diagnosed histopathologically.
Autor:innen und Institutionen
- Department of Clinical Oncology, Akita University Graduate School of Medicine, 1-1-1 Hondo, Akita 010-8543, Japan.
Zitieren
APA
Otsuka, K., Takahashi, M., Nanjo, H., Miyazawa, H., Iida, M., Abe, Y., Jin, M., Onishi, H., Hashimoto, M., Yamamoto, Y., & Shibata, H. (2011). 18 FDG-PET at 1-Month Intervals Is a Better Predictive Marker for GISTs That Are Difficult to Be Diagnosed Histopathologically: A Case Report. Case Reports in Oncological Medicine. https://doi.org/10.1155/2011/638794
Vancouver
Otsuka K, Takahashi M, Nanjo H, Miyazawa H, Iida M, Abe Y, et al. 18 FDG-PET at 1-Month Intervals Is a Better Predictive Marker for GISTs That Are Difficult to Be Diagnosed Histopathologically: A Case Report. Case Reports in Oncological Medicine. 2011. doi:10.1155/2011/638794
BibTeX
@article{Otsuka2011,
author = {Otsuka, Kazunori and Takahashi, Masahiro and Nanjo, Hiroshi and Miyazawa, Hideaki and Iida, Masatake and Abe, Yuki and Jin, Mario and Onishi, Hirohide and Hashimoto, Manabu and Yamamoto, Yuzo and Shibata, Hiroyuki},
title = {18 FDG-PET at 1-Month Intervals Is a Better Predictive Marker for GISTs That Are Difficult to Be Diagnosed Histopathologically: A Case Report},
journal = {Case Reports in Oncological Medicine},
year = {2011},
doi = {10.1155/2011/638794}
}
EUVIMED